Dianthus Therapeutics is up 320% in a Year. One Major Investor Just Reduced Its Stake but Still Seems Bullish
Dianthus Therapeutics Is Up 320% in a Year. One Major Investor Just Reduced Its Stake but Still Seems Bullish Octagon Capital Advisors cut its stake in Dianthus Therapeutics (NASDAQ:DNTH) by 470,000 shares, an estimated $27.22 million trade based on quarterly average prici